Skip to content

Imaging and Physiologic Evaluation of Coronary Artery Disease

Imaging and Physiologic Evaluation of Coronary Artery Disease: a Prospective Registry Study (IP-CAD)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05124249
Enrollment
2000
Registered
2021-11-17
Start date
2021-11-01
Completion date
2030-12-31
Last updated
2026-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atherosclerosis, Ischemic Heart Disease

Keywords

Percutaneous Coronary Intervention, Intravascular Imaging, Intravascular Ultrasound, Optical Coherence Tomography, Fractional flow reserve

Brief summary

To evaluate the long-term clinical outcomes and prognostic factors in patients with coronary artery disease (CAD) undergoing invasive coronary angiography (ICA), intravascular imaging, or invasive physiologic assessment.

Detailed description

The traditional standard method for evaluating coronary artery disease (CAD) is invasive coronary angiography (ICA). ICA enables the assessment of anatomic severity of the epicardial artery and the severity of diameter stenosis can be closely associated with myocardial ischemia. However, there remains concern that anatomical severity is not always identical with functional significance. Actually, even the patients showed positive non-invasive tests including treadmill test, stress echocardiography, coronary computed tomography angiography, or nuclear imaging, less than half of the patients showed significant stenosis on ICA. Therefore, the investigators need further investigation to overcome the limitations of ICA. In this regard, intravascular imaging, such as intravascular ultrasound (IVUS) and optical coherence tomography (OCT), is a useful tool for assessing the anatomical severity in more detail. Those imaging modalities produce cross-sectional images of CAD and imaging modalities are allowing to assess lesion characteristics, plaque morphology, treatment planning, and optimization of the implanted stent. Furthermore, imaging-guided percutaneous coronary intervention (PCI) has been shown favorable outcomes, compared with angiography only-guided PCI, especially in complex lesions. Meanwhile, there has been an ample body of evidence that invasive coronary physiology assessment, such as fractional flow reserve (FFR), also can be useful for assessing the functional significance. Therefore, the current guidelines have continuously recommended intracoronary imaging and invasive physiologic assessment for guiding the treatment of CAD. The aim of the IP-CAD (Imaging and Physiologic Evaluation of Coronary Artery Disease: a Prospective Registry Study) is to evaluate the long-term clinical outcomes according to the imaging-guided or physiology-guided PCI in real-world practice.

Interventions

DIAGNOSTIC_TESTIntravascular imaging (IVUS or OCT) or Invasive physiologic assessment

Intravascular imaging (IVUS or OCT) or Invasive physiologic assessment

PROCEDUREPCI

Patients who undergoing PCI

Sponsors

Chonnam National University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Subject must be at least 18 years of age * Subjects who suspected ischemic heart disease and underwent ICA. * Subjects who were performed intravascular imaging or invasive physiologic assessment

Exclusion criteria

* Subject with Age \<18 years * Pregnant women

Design outcomes

Primary

MeasureTime frameDescription
MACE3-Year after the index procedurea composite of all-cause death, myocardial infarction, or any revascularization

Secondary

MeasureTime frameDescription
Rate of all-cause death3-Year after the index proceduredeath from any-cause
Rate of cardiac death3-Year after the index proceduredeath from cardiac-cause
Rate of myocardial infarction3-Year after the index procedureMyocardial infarction without peri-procedural myocardial infarction
Rate of target lesion revascularization3-Year after the index procedureischemia-driven or all
Rate of target vessel revascularization3-Year after the index procedureischemia-driven or all
Rate of any revascularization3-Year after the index procedureischemia-driven or all
Rate of stent thrombosis3-Year after the index proceduredefinite or probable
Rate of ischemic or hemorrhagic stroke3-Year after the index procedureIschemic or hemorrhagic stoke by braing imaging
Rate of BARC type 2,3, or 5 bleeding3-Year after the index procedureBleeding Academic Research Consortium (BARC) type 2,3 or 5 bleeding
MACCE3-Year after the index procedurea composite of all-cause death, myocardial infarction, any revascularization, and ischemic or hemorrhagic stroke

Countries

South Korea

Contacts

CONTACTYoung Joon Hong, MD, PhD
hyj200@hanmail.net82-62-220-5778
CONTACTSeung Hun Lee, MD, PhD
lsh8602@naver.com82-62-220-4246
PRINCIPAL_INVESTIGATORYoung Joon LeeHong, MD, PhD

Chonnam National University Medical School; Chonnam National University Hospital

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 19, 2026